相关人员
As a lawyer specialising in pharmaceutical and IP law, Manja has been advising pharmaceutical and biotechnology companies, medical device manufacturers, and food producers on all matters relating to intellectual property and regulatory questions for many years.
A focus of her practice involves advising clients on contractual projects of a complex and cross-border nature, in particular, research and development cooperations, manufacturing agreements, distribution agreements, licencing agreements, as well as providing advise on all matters relating to transactions.
Since 2010 | Partner, Taylor Wessing |
2005 – 2010 | Partner, Ashurst LLP |
2002 – 2005 | Associate, Ashurst LLP |
1996 – 2002 | Associate, Taylor Wessing |
1993 – 1995 | Legal clerkship, Munich |
1998 | Doctoral degree, dissertation on a theme of international private arbitration, LMU Munich |
1996 | Admitted as a lawyer, Munich |
1995 | Second state examination, Munich |
1993 | First state examination, Munich |
1993 | Legal degree, LMU, Munich |
1990 | Studies in international law, University Paul Cézanne, Aix-Marseille III |
1989 | Law degree, University of Tübingen |
1988 | Law degree, University of Mainz |
„Werbung für Arzneimittel“ auch bei Bezug zu unbestimmten Arzneimitteln gegeben, in: GRUR-Prax, 2023 |
Deutsche Vereinigung für gewerblichen Rechtsschutz und Urheberrecht |
English |
French |
最新新闻和观点
The Long and Winding Road: (Some) EU and FDA Issues to Consider with Clinical Trials and Clinical Trial Agreements
作者 Dr. Manja Epping 以及 Irina Rebin
The EU Commission's new pharmaceutical package: amended legal framework for data protection, marketing protection and market exclusivity
作者 Dr. Manja Epping 以及 Sherin Sayed
The European Commission's pharmaceutical reform package: core objectives and planned changes at a glance
作者 Dr. Manja Epping 以及 Sherin Sayed
The CJEU: The recurring question of the separation of medicinal products and medical devices
作者 Dr. Manja Epping 以及 Sherin Sayed